These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26010310)

  • 1. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
    Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
    Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Purnak T; Efe C; Kav T; Wahlin S; Ozaslan E
    Dig Dis Sci; 2017 Oct; 62(10):2900-2907. PubMed ID: 28871464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
    Kanzler S; Löhr H; Gerken G; Galle PR; Lohse AW
    Z Gastroenterol; 2001 May; 39(5):339-41, 344-8. PubMed ID: 11413913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis.
    Khonde P; Choudhury S; Spies NC; Naz N; Stoll J; Fleckenstein J; He M; Ballentine S; Kulkarni S
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102442. PubMed ID: 39103121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Ben Merabet Y; Barbe C; Heurgue-Berlot A; Thévenot T; Minello A; Habersetzer F; Samuel D; Bernard-Chabert B; Weil-Verhoeven D; Renard P; Clot H; Di Martino V; Louvet H; Bresson-Hadni S; Thiéfin G
    Dig Dis Sci; 2021 Jun; 66(6):2107-2117. PubMed ID: 32607807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
    Li YN; Ma H; Zhou L; Zhang J; Guo LP; Li SQ; Qian YQ; Wang BM
    Chin Med J (Engl); 2016 Oct; 129(20):2434-2440. PubMed ID: 27748335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
    Franulović OZ; Rajacić N; Lesar T; Kuna AT; Morić BV
    Coll Antropol; 2012 Sep; 36(3):973-9. PubMed ID: 23213960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH; Gearry RB; Frampton CM; Stedman CA
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
    Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
    J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Abdel-Razik A; Mousa N; Zakaria S; Elhelaly R; Elzehery R; Zalata K; Awad M; Eldeeb AA; Abdelsalam M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1373-1379. PubMed ID: 29035910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
    Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
    Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
    Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
    J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard Treatment in Adults: Which Steroid? Or without Steroids?
    Gleeson D
    Dig Dis; 2015; 33 Suppl 2():75-82. PubMed ID: 26640942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.